(Total Views: 142)
Posted On: 03/27/2019 11:26:04 PM
Post# of 150068
That’s kinda what I was thinking, but thank you for clarifying! In other words once the CCR5 density threshold is determined, those above 700 mg dose threshold will likely not respond to leronlimab and be stuck on HAART regiment.
I think I know the answer to this also, but would FDA allow for twice a week injections at 700 mg without additional trials to treat these high density CCR5 patients?
I think I know the answer to this also, but would FDA allow for twice a week injections at 700 mg without additional trials to treat these high density CCR5 patients?
(0)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
Scroll down for more posts ▼
